PIN38- COST-EFFECTIVENESS OF LOPINAVIR/RITONAVIR COMPARED TO NELFINAVIR AS FIRST-LINE ANTIRETROVIRAL THERAPY IN TREATMENTNAVE HIV PATIENTS- A MANAGED CARE PERSPECTIVE
Abstract
Authors
MP Luo MF Botteman O Grad MA Cifaldi T Ashraf